Literature DB >> 14516027

Venous leg ulcers after hip replacement. A clinical evaluation at 5 to 12 years.

J S Mehta1, N Nicolaou, S Kiryluk, M J F Fordyce.   

Abstract

Venous ulceration is a chronic disabling complication of deep-vein thrombosis. The aim of this study was to estimate the incidence of venous leg ulcers five years or more after total hip replacement (THR) and to investigate some of the clinical features associated with their development. We carried out a postal survey of all patients who had undergone a THR 5 to 12 years previously. Replies from 816 patients showed that 66 (8.1%) had a history of leg ulcers. The prevalence of active ulceration was 2.6% and 43 patients (5.3%) reported developing ulceration since their hip replacement. A clinical review determined that 31 (3.8%) of these were true venous ulcers. The ulcers occurred more commonly on the operated side and developed at a mean of 5.8 years (18 months to 12 years) after the first arthroplasty. A mean of 1.9 arthroplasties (1 to 5) (primary and revision) were carried out before the ulcers appeared. The overall incidence of ulcers was similar to that in the general population.

Entities:  

Mesh:

Year:  2003        PMID: 14516027     DOI: 10.1302/0301-620x.85b7.14196

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  3 in total

1.  Are national guidelines for total hip replacement in the UK reflected in practice?

Authors:  A Abraham; L Hajipour; A R Innes; H Phillips; A W McCaskie
Journal:  Ann R Coll Surg Engl       Date:  2006-03       Impact factor: 1.891

2.  Evaluation of deep vein thrombosis with multidetector row CT after orthopedic arthroplasty: a prospective study for comparison with Doppler sonography.

Authors:  Sung Su Byun; Jeong Ho Kim; Youn Jeong Kim; Yong Sun Jeon; Yong Sun Chun; Chul Hi Park; Won Hong Kim
Journal:  Korean J Radiol       Date:  2008 Jan-Feb       Impact factor: 3.500

3.  Patient-reported history of leg ulceration 12-16 years after total primary knee or hip replacement.

Authors:  Virginia C Gould; Vikki Wylde; Alison J Smith; Ashley W Blom
Journal:  Acta Orthop       Date:  2011-07-13       Impact factor: 3.717

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.